Acceleron Pharma Inc.

NASDAQ: XLRN · Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Ratios and Metrics

Financials in USD. Fiscal year is undefined.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
PE Ratio
-37.21 -29.99 -32.36
PEG Ratio
-3.55 n/a -3.07
PS Ratio
306.65 272.74 331.82
PB Ratio
14.60 9.99 10.13
P/FCF Ratio
-143.08 -89.25 -119.33
P/OCF Ratio
-147.94 -90.27 -120.95
OCF/S Ratio
-2.07 -3.02 -2.74
Debt / Equity Ratio
0.03 0.03 0.03
Quick Ratio
12.14 12.07 14.81
Current Ratio
12.14 12.07 14.81
Asset Turnover
0.04 0.03 0.03
Interest Coverage
n/a n/a n/a
Return on Equity
-0.1 -0.08 -0.08
Return on Assets
-0.09 -0.08 -0.07
Return on Invested Capital
-0.1 -0.08 -0.08
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00
Net Profit Margin
-2.06 -2.27 -2.56
Pretax Profit Margin
-2.06 -2.27 -2.56
Operating Profit Margin
-2.07 -2.28 -2.57
FCF Margin
n/a n/a n/a
EBITDA Margin
-2.03 -2.24 -2.52